Evidence map›Paper›PMID 22420714›Full record

ArticleThe FEBS journal2012

The response of PKD1L3/PKD2L1 to acid stimuli is inhibited by capsaicin and its pungent analogs.

Sho Ishii, Azusa Kurokawa, Mikiya Kishi, Keigo Yamagami, Shinji Okada, Yoshiro Ishimaru, Takumi Misaka

Open access · bronzeAbstract read
In one paragraph

Article in The FEBS journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. The orotrigeminal system.Handbook of clinical neurology · 2019
    Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sho IshiiCentral Research Institute, Mizkan Group Co., Handa, Aichi, Japan.
Azusa Kurokawa
Mikiya Kishi
Keigo Yamagami
Shinji Okada
Yoshiro Ishimaru
Takumi Misaka
Tokyo University of Pharmacy and Life Sciences · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycystic kidney disease (PKD) 2L1 protein is a member of the transient receptor potential (TRP) ion channel family. In circumvallate and foliate papillae, PKD2L1 is coexpressed with PKD1L3. PKD2L1 and PKD1L3 interact through their transmembrane domain and the resulting heteromer PKD1L3/PKD2L1 owns a unique channel property called 'off-responses' to acid stimulation, although PKD2L1 does not own this property by itself. To define the pharmacological properties of the PKD1L3/PKD2L1 channel, we developed a new method to effectively evaluate channel activity using human embryonic kidney 293T cells in which the channel was heterologously expressed. This method was applied to screen substances that potentially regulate it. We found that capsaicin and its analogs, which are TRPV1 agonists, inhibited the response to acid stimuli and that the capsaicin inhibition was reversible with an IC(50) of 32.5 μm. Capsaicin and its analogs are thus useful tools for physiological analysis of PKD1L3/PKD2L1 function.

Indexed as

AnimalsCalcium ChannelsCapsaicinCells, CulturedHEK293 CellsHumansMaleMiceMice, Inbred BALB CMolecular Sequence DataReceptors, Cell SurfaceSensory System AgentsTaste BudsTongueTRPP Cation ChannelsCalcium ChannelsCapsaicinPKD1L3 protein, mousePkd2l1 protein, mouseReceptors, Cell SurfaceSensory System AgentsTRPP Cation Channels

Identifiers

PMID22420714
PMCPMC3492849
OpenAlexW1617131075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.